(Q28307175)
Statements
A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy (English)
0 references
May 2011
0 references
127
0 references
1309-10.e1
0 references
5
0 references